Skip to main content
Equibles
NKTR $73.02 -3.82%
NKTR logo

NKTR · Nektar Therapeutics

Track NKTR — free

Use NKTR with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about NKTR

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$73.02 -2.90 (-3.82%) At close · Aug 14
Market Cap
$2.49B
Shares
34.14M
All earnings calls

Earnings call · FY2022 Q4

Nektar Therapeutics Q4 FY2022 Earnings Call

Nektar Therapeutics Q4 FY2022 Earnings Call

Concluded Jan 9, 2023
Jan 9, 2023 0 turns
Period
FY2022 Q4
Runtime
—
Sources
2 artifacts
8-K 10-K

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue · derived Q4 $22.02M -11.9% YoY
Net income · derived Q4 -$59.69M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Jan 9, 2023 10-K report Filed Feb 28, 2023
Full-screen source Call document

Report a Problem

Category
Description
Email (optional, for follow-up)